Lupin up 2.5% on Russia's Biocom acquisition
Shares of drug major Lupin on Friday gained 2.5 percent after the company announced acquisition of Russia's Biocom, marking its foray into the Russian pharma market, which is expected to be one of the top eight in the world by 2018.
Jul 03, 2015, 13:43 PM IST